110 related articles for article (PubMed ID: 23692545)
21. Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis.
Chen YJ; Shen JL; Wu CY; Chang YT; Chen CM; Lee FY
J Am Acad Dermatol; 2009 Feb; 60(2):225-30. PubMed ID: 19028408
[TBL] [Abstract][Full Text] [Related]
22. Association of vitamin D receptor (Fok-I) polymorphism with the clinical presentation of calcium urolithiasis.
Liu CC; Huang CH; Wu WJ; Huang SP; Chou YH; Li CC; Chai CY; Wu MT
BJU Int; 2007 Jun; 99(6):1534-8. PubMed ID: 17419705
[TBL] [Abstract][Full Text] [Related]
23. A polymorphism of the osteopontin gene is related to urinary calcium stones.
Gao B; Yasui T; Okada A; Tozawa K; Hayashi Y; Kohri K
J Urol; 2005 Oct; 174(4 Pt 1):1472-6. PubMed ID: 16145474
[TBL] [Abstract][Full Text] [Related]
24. Association of the osteopontin rs1126616 polymorphism and a higher serum osteopontin level with lupus nephritis.
Salimi S; Noora M; Nabizadeh S; Rezaei M; Shahraki H; Milad MK; Naghavi A; Farajian-Mashhadi F; Zakeri Z; Sandoughi M
Biomed Rep; 2016 Mar; 4(3):355-360. PubMed ID: 26998275
[TBL] [Abstract][Full Text] [Related]
25. Quantification of osteopontin in the urine of healthy and stone-forming men.
Yasui T; Fujita K; Hayashi Y; Ueda K; Kon S; Maeda M; Uede T; Kohri K
Urol Res; 1999 Aug; 27(4):225-30. PubMed ID: 10460890
[TBL] [Abstract][Full Text] [Related]
26. Association of osteopontin gene haplotypes with nephrolithiasis.
Gao B; Yasui T; Itoh Y; Li Z; Okada A; Tozawa K; Hayashi Y; Kohri K
Kidney Int; 2007 Sep; 72(5):592-8. PubMed ID: 17519954
[TBL] [Abstract][Full Text] [Related]
27. Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma.
Dong QZ; Zhang XF; Zhao Y; Jia HL; Zhou HJ; Dai C; Sun HJ; Qin Y; Zhang WD; Ren N; Ye QH; Qin LX
Hepatology; 2013 Mar; 57(3):1024-34. PubMed ID: 23079960
[TBL] [Abstract][Full Text] [Related]
28. The 795CT polymorphism in osteopontin gene is not associated with multiple sclerosis in a Spanish population.
Mas A; MartÃnez A; de las Heras V; Bartolomé M; de la Concha EG; Arroyo R; Urcelay E
Mult Scler; 2007 Mar; 13(2):250-2. PubMed ID: 17439891
[TBL] [Abstract][Full Text] [Related]
29. Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer.
Chang YS; Kim HJ; Chang J; Ahn CM; Kim SK; Kim SK
Lung Cancer; 2007 Sep; 57(3):373-80. PubMed ID: 17513004
[TBL] [Abstract][Full Text] [Related]
30. A genetic polymorphism in transforming growth factor beta receptor-2 is associated with serum osteopontin.
Biros E; Clancy P; Norman PE; Golledge J
Int J Immunogenet; 2009 Aug; 36(4):241-4. PubMed ID: 19601999
[TBL] [Abstract][Full Text] [Related]
31. Association of vitamin D receptor gene Taq I polymorphism with recurrent urolithiasis in children.
Seyhan S; Yavascaoglu I; Kilicarslan H; Dogan HS; Kordan Y
Int J Urol; 2007 Dec; 14(12):1060-2. PubMed ID: 18036039
[TBL] [Abstract][Full Text] [Related]
32. Investigation of osteopontin levels and genomic variation of osteopontin and its receptors in Type 1 diabetes mellitus.
Karamizadeh Z; Kamali Sarvestani E; Saki F; Karamifar H; Amirhakimi GH; Namavar Shooshtarian MH; Ashkani-Esfahani S
J Endocrinol Invest; 2013 Dec; 36(11):1090-3. PubMed ID: 24084141
[TBL] [Abstract][Full Text] [Related]
33. Local factors compared with systemic factors in the formation of bladder uric acid stones.
Li WM; Chou YH; Li CC; Liu CC; Huang SP; Wu WJ; Huang CH
Urol Int; 2009; 82(1):48-52. PubMed ID: 19172097
[TBL] [Abstract][Full Text] [Related]
34. Serum osteopontin, but not OPN gene polymorphism, is associated with LVH in essential hypertensive patients.
Hou X; Hu Z; Huang X; Chen Y; He X; Xu H; Wang N
J Mol Med (Berl); 2014 May; 92(5):487-95. PubMed ID: 24370940
[TBL] [Abstract][Full Text] [Related]
35. [Association between genetic polymorphism of erythrocyte CR1 and the susceptibility of idiopathic pulmonary fibrosis].
Yuan YD; Zhao MX; Yu J
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Nov; 34(11):841-5. PubMed ID: 22333472
[TBL] [Abstract][Full Text] [Related]
36. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.
Naito M; Matsui A; Inao M; Nagoshi S; Nagano M; Ito N; Egashira T; Hashimoto M; Mishiro S; Mochida S; Fujiwara K
J Gastroenterol; 2005 Apr; 40(4):381-8. PubMed ID: 15868370
[TBL] [Abstract][Full Text] [Related]
37. Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis.
Choi ST; Kim JH; Kang EJ; Lee SW; Park MC; Park YB; Lee SK
Rheumatology (Oxford); 2008 Dec; 47(12):1775-9. PubMed ID: 18854347
[TBL] [Abstract][Full Text] [Related]
38. Comparison of biochemistry and diet in patients with enterocystoplasty who do and do not form stones.
Hamid R; Robertson WG; Woodhouse CR
BJU Int; 2008 Jun; 101(11):1427-32. PubMed ID: 18284409
[TBL] [Abstract][Full Text] [Related]
39. Association between eight adiponectin polymorphisms, obesity, and metabolic syndrome parameters in Tunisian volunteers.
Boumaiza I; Omezzine A; Rejeb J; Rebhi L; Rejeb NB; Nabli N; Abdelaziz AB; Bouslama A
Metab Syndr Relat Disord; 2011 Dec; 9(6):419-26. PubMed ID: 21870907
[TBL] [Abstract][Full Text] [Related]
40. High plasma osteopontin levels in patients with inflammatory bowel disease.
Mishima R; Takeshima F; Sawai T; Ohba K; Ohnita K; Isomoto H; Omagari K; Mizuta Y; Ozono Y; Kohno S
J Clin Gastroenterol; 2007 Feb; 41(2):167-72. PubMed ID: 17245215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
